ATYR Earnings

Quarterly EPS
$-7.22
Q4 2024
$-6.80
Q1 2025
$-8.80
Q2 2025
$-10.60
Q3 2025
$-5.69
Q4 2025
$-4.40
Q1 2026
$-4.40
Q2 2026
$-7.43
Q3 2026
Latest RevenueN/A
Latest Net Income-18257000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q3 2026-$7.430-18257000-100.0%+29.9%
Q2 2026-$4.400-10310000—+50.0%
Q1 2026-$4.400-10792000—+35.3%
Q4 2025-$5.690-13964000—+21.2%
Q3 2025-$10.60190.0K-25746000—-15.2%
Q2 2025-$8.800-19532000—+4.3%
Q1 2025-$6.800-14881000——
Q4 2024-$7.220-14968000——
Q3 2024-$9.200-17261000——
Q2 2024-$9.200-16306000——
aTyr Pharma (ATYR) — Earnings